TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 8505 participants.

Also called NCT03596385

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 8,505 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03596385
Other papers using this trial's data
  • Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction The New England journal of medicine, 2025-11-13 DOI, PubMed 40888702
  • Beta-blockers after invasively managed STEMI vs NSTEMI without reduced ejection fraction: a prespecified analysis from the REBOOT trial Revista espanola de cardiologia (English ed.), 2026-10 DOI, PubMed 42034335

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Italy, Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03596385. Randomized; no masking; primary purpose treatment. Start 2018-10-31 (actual); primary completion 2025-01-31 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
TREatment With Beta-blockers After myOcardial Infarction withOut Reduced Ejection fracTion"
Intervention (Drug)
Beta blocker
Lead sponsor
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (class: other)

Record details

Record id
cardio:ct-nct03596385
Content hash
668323cae480dadd948102297570da4f47ba1daff0e1f80fa046d73d858888fc